Diovan Hct
News for Diovan Hct
Lupin achieves an important milestone with the launch of and Hydrochlorothiazide Tablets, the generic version of Novartis' hypertension drug Diovan... ...
http://www.equitybulls.com/admin/news2006/news_det.asp?id=117724"We think the imminent catalyst for Cipla is likely to emerge as the Medpro acquisition, which we expect will receive a shareholder approval at the... ...
http://www.moneycontrol.com/news/market-outlook/bullishcipla-medpro-buy-key-catalyst-espirito-santo_843140.htmlLupin rose 1.46% to Rs 637 at 11:15 IST on BSE, after the company's subsidiary Lupin Pharmaceuticals Inc. received final approval for its Valsartan... ...
http://www.indiainfoline.com/Markets/News/Lupin-strikes-record-high-after-launch-of-generic-Diovan-HCT-tablets/4798634533Venus is eyeing Rs 25 crore from the sale of this new product from a market that pegged at Rs 100 crore. "We believe that we would be able to... ...
http://www.moneycontrol.com/news/business/new-otc-drug-to-garner-rs-25cr-revenues-venus-remedies_842763.htmlValsartan and Hydrochlorothiazide Tablets USP, 80/12.5 mg, 160/12.5 mg, 160/25 mg, 320/12.5 mg and 320/25 mg had annual U.S sales of approximately... ...
http://www.indiainfoline.com/Markets/News/Lupin-gets-USFDA-approval-for-new-drugs/5644958781Related Tags
Top Coverage News
© 2013 Rediff.com - Investors - Advertise - Disclaimer - Privacy - Careers - Feedback | Terms of use | India Abroad weekly